Glaucoma is an eye disease resulting
in the loss of eyesight due to fluid
accumulation inside the eyeball
which in turn builds-up pressure
over the optic nerve, eventually
leading to blindness.
A new drug developed by the US-based Pharmacia Upjohn Incorporated, latanoprost, is more effective than the standard drug for glaucoma,timolol. The latter is known to have numerous side-effects ranging from respiratory problems to irregular heartbeats also, people with hearing or respiratory problems cannot use it. Latanoprost, significantly, has fewer side-effects. But what worries scientists is the unfamiliar transformation of blue and green eyes to the colour brown with the use of latanoprost.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.